European Journal of Chemistry

Identification and characterization of geometrical isomeric photo degradation product of eprosartan using LC-MS and LC-NMR



Main Article Content

Ravi Piyushkumar Shah
Archana Sahu
Saranjit Singh

Abstract

The degradation of eprosartan was evaluated under ICH/WHO prescribed stress conditions. The drug degraded to only one product under photo alkali condition, whereas it was stable to conditions of hydrolysis, oxidation and thermal stress. The drug and its co-eluting product were well separated on RP-HPLC in a gradient mode. Subsequently, LC-MS/TOF and on-line H/D exchange studies were performed on both of them. The two showed same molecular mass, similar fragment ions and even the same number of labile hydrogens indicating the product to be an isomer of the drug. To confirm the same, 1H and COSY LC-NMR studies were carried out by using an enriched sample. Distinguishing behaviour of chemical shifts proved the product to be (Z)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-enyl)-1H-imidazol-1-yl)methyl)benzoic acid. The structure was further supported by differential LC-MS ion intensities of the drug and the product.2_2_152_157_800

icon graph This Abstract was viewed 5653 times | icon graph Article PDF downloaded 2686 times

How to Cite
(1)
Shah, R. P.; Sahu, A.; Singh, S. Identification and Characterization of Geometrical Isomeric Photo Degradation Product of Eprosartan Using LC-MS and LC-NMR. Eur. J. Chem. 2011, 2, 152-157.

Article Details

Author Biography

Archana Sahu, Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar 160062, Punjab, India

Scientist; Dept. of Pharmaceutical Analysis
Share
Crossref - Scopus - Google - European PMC
References

[1]. ICH Topic Q1A (R2), Stability Testing of New Drug Substances and Products, in: International Conference on Harmonisation, IFPMA, Geneva, 2003.

[2]. WHO, Draft Stability Testing of Active Pharmaceutical Ingredients and Pharmaceutical Products, World Health Organization, Geneva, 2007.

[3]. Murakami, T.; Kawasaki, T.; Takemura, A.; Fukutsu, N.; Kishi, N.; Kusu, F. J. Chromatogr. A 2008, 1208, 164-174.
doi:10.1016/j.chroma.2008.08.076
PMid:18778828

[4]. Shah, R. P.; Kumar, V.; Singh, S. Rapid Commun. Mass Spectrom. 2008, 22, 613-622.
doi:10.1002/rcm.3403
PMid:18247406

[5]. Novak, P.; Tepes, P.; Ilijas, M.; Fistric, I.; Bratos, I.; Avdagic, A.; Hamersak, Z.; Markovic, V. G.; Dumic, M. J. Pharm. Biomed. Anal. 2009, 50, 68-72.
doi:10.1016/j.jpba.2009.03.017
PMid:19410412

[6]. Dev, R. V.; Kiran, G. S. U.; Subbaiah, B. V.; Babu, B. S.; Babu, J. M.; Dubey, P. K.; Vyas, K. Magn. Reson. Chem. 2009, 47, 443-448.
doi:10.1002/mrc.2404
PMid:19173350

[7]. Shah, R. P.; Sahu, A.; Singh, S. J. Pharm. Biomed. Anal. 2010, 51, 1037-1046.
doi:10.1016/j.jpba.2009.11.008
PMid:20018473

[8]. Shah, R. P.; Singh, S. J. Pharm. Biomed. Anal. 2010, 53, 755-761.
doi:10.1016/j.jpba.2010.05.005
PMid:20554147

[9]. Hoffman, B. B. in: Brunton, L.L. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th Edition, McGraw-Hill, 859-860, 2006.

[10]. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?Fuseaction=Search.DrugDetails (accessed on 11 April 2011).

[11]. Hsu, L. C. J. Liq. Chrom. & Rel. Technol. 1998, 21, 1685-1700.
doi:10.1080/10826079808001252
PMCid:1176066

[12]. Xue-Ning, L.; Hong-Rong, X.; Wei-Li, C.; Gang-Yi, L.; Nan-Nan. C.; Chen Y. J. Chromatogr. B 2007, 853, 47-53.

[13]. Ferreirós, N.; Iriarte, G.; Alonsoa, R. M.; Jiménez, R. M.; Ortíz, E. J. Chromatogr. A 2006, 1119, 309-314.
doi:10.1016/j.chroma.2006.02.055
PMid:16542666

[14]. ICH Topic Q1B, Stability Testing: Photostability Testing of New Drug Substances and Products, in: International Conference on Harmonisation, IFPMA, Geneva, 1996.

[15]. Bakshi, M.; Singh, S. J. Pharm. Biomed. Anal. 2002, 28, 1011-1040.
doi:10.1016/S0731-7085(02)00047-X

[16]. Mayer-Helm, B.; Hofbauer, L.; Pani, J. J. Mass. Spectrom. 2010, (Article in Press; doi:10.1002/jms.1757).

[17]. Ge, G. B.; Zhang, R.; Ail, C. Z.; He Y. Q.; Zhang Y. Y.; Liu X. B.; Yang L.; Wang Z. T.; Yang L. Rapid Commun. Mass Spectrom. 2009, 23, 425-432.
doi:10.1002/rcm.3892
PMid:19125430

[18]. Brum, J.; Hannah, R. Rapid Commun. Mass Spectrom. 1997, 11, 1430-1434.
doi:10.1002/(SICI)1097-0231(19970830)11:13<1430::AID-RCM7>3.0.CO;2-5

[19]. Thoma, K.; Kuebler, N.; Reimann, E. Pharmazie 1997, 52, 362-373.
PMid:9229718

[20]. Albini, A.; Fasani, E. in: Tønnesen H. H. The Photostability of Drugs and Drug Formulations, 2nd Edition, Taylor and Francis, 69-71, 2004.

Supporting Agencies

Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).